Is WST stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-22, West Pharmaceutical Services Inc. (NYSE: WST) is rated B+ (Buy / BUY) by Roarable's 5-pillar RQD engine with a composite confidence score of 76/100 at a spot price of $396.64 (-1.83% 1D, market cap $27.63B). Pillar breakdown: Fundamental Cash Engine 18/20, Institutional 13F & Options Flow 14/20, SEC Balance-Sheet Forensics 18/20, FRED Macro Regime Fit 15/20, and Executive Insider Alignment 11/20. Across 1015 tracked Health Care issuers, WST ranks #17 in composite RQD confidence.